Curtiss-Wright Corporation

▲ Bull Case

• ◆Commercial nuclear segment becomes the durable growth engine through SMR partnerships converting to multi-year revenue commitments and commercial nuclear aftermarket compounding at 15-25% as plant life extensions and data-center-driven uprates accelerate. Commercial segment reaches $2.0-2.2B by 2030 versus ~$1.1B in 2025, driving total revenue to $5.7-6.1B and FY 2030 adjusted EPS to $27-29, supporting $945-$1,015/share at a sustained 35x multiple.
• ◆Naval nuclear dual-ramp materializes faster than consensus with Columbia-class accelerating concurrently at 2/yr and AUKUS Pillar 2 work contributing materially by 2027-2028. Naval segment revenue grows 12-15% annually versus Street's 8-10%, providing $1.50-2.00 EPS upside versus base case.
• ◆Industrials divestiture catalyst converts CW into a pure-play defense and nuclear infrastructure company eligible for full BWXT/HEICO multiple convergence at 40-45x forward, justifying $700-$900/share even on base operating performance and eliminating legacy industrial drag on the multiple.

▼ Bear Case

• ◆Multiple compression dominates earnings growth as forward P/E reverts from 48x toward defense-quality average of 22-25x as the nuclear-renaissance narrative cools. Even with 15% annual EPS growth, multiple-compression-driven losses produce 40-55% downside over 2-3 years (FY 2027E $18.22 at 22x = $401 versus current $747).
• ◆Commercial nuclear and SMR commercialization disappoints as projects face permitting, cost, and scheduling delays typical of nuclear industry planning fallacy. Commercial segment grows at 5-7% rather than 13%+ implied by current valuation, and normalized defense multiple combination produces $300-$350 fair value (-55% downside).
• ◆Defense budget renegotiation pressures naval shipbuilding with post-2026 fiscal pressure reducing submarine procurement rate by 10-15% or pushing Columbia-class timeline. CW's most-protected revenue stream becomes incrementally uncertain, and risk-off de-rating compresses CW to defense-prime multiples of ~18x, producing $260-300 fair value (-60% to -65% downside).

“The consensus debate has shifted from 'is CW a quality compounder' (resolved affirmatively) to whether CW should be classified as a nuclear infrastructure pure-play deserving BWXT/HEICO multiples or as a defense compounder with attractive optionality that has been temporarily over-priced. Bulls argue the secular nuclear demand shock from AI data centers, plant life extensions, SMR commercialization, and AUKUS-driven naval submarine procurement supports a permanent multiple re-rating to 35-45x. Bears argue the multiple has run far ahead of segment-mix reality (Commercial Nuclear is still only 25-30% of revenue) and that moderation in the AI-power narrative will trigger sharp multiple compression. Street consensus 12-month price target is approximately $637, already below current trading levels, suggesting even sell-side analysts have not fully embraced the bull-case multiple.”

• ◆Commercial Nuclear segment growth exceeding 20% year-over-year in any quarter within 12 months (high magnitude, medium-high probability) would validate the bull case thesis
• ◆SMR partnership with Rolls-Royce converted to multi-year revenue contract with delivery schedule by Q4 2027 (high magnitude, medium probability) would monetize the commercial nuclear opportunity
• ◆FY 2026 EPS beat at $15.50+ versus guidance midpoint of $15.10 by February 2027 (medium magnitude, high probability) would extend the beat-and-raise track record
• ◆Industrials/specialty controls divestiture announcement (very high magnitude, low-medium probability) would catalyze multiple re-rating to pure-play nuclear/defense classification
• ◆AUKUS Pillar 2 multi-year contract award within 12-18 months (medium-high magnitude, medium probability) would validate international submarine program exposure

• ◆Multiple compression from current 48x forward to 25x defense-quality average (high probability, very high impact) is the single dominant determinant of forward return and the largest risk given current pricing
• ◆Commercial nuclear and SMR commercialization delays (medium probability, high impact) due to permitting, cost overruns, and scheduling slippage as historically occurs in nuclear projects would collapse the bull case
• ◆Defense budget renegotiation cutting naval shipbuilding by 10-15% or pushing Columbia-class timeline (low-medium probability, high impact) would pressure CW's most-protected revenue stream
• ◆Material nuclear quality event industry-wide (very low probability, very high impact) could suppress commercial nuclear demand for multiple years
• ◆Government shutdown or extended continuing resolution (high probability, low impact) creates near-term operational friction